Clinical Trial Update: A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating starting therapy with Janumet (sitagliptin/metformin) versus metformin alone in adults with Type 2 diabetes mellitus to as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Janumet (sitagliptin/metformin)
• metformin (metformin)

Snippet

Sponsor: Meir Medical Center | Conditions: Diabetes Type 2 | Phase 3 | Status: UNKNOWN